Non-invasive
Quick treatment times
Fewer treatments
No side effects
UroGold’s low intensity (Li-ESWT) proprietary electrohydraulic acoustic shockwave allows energy to be applied over a large focused treatment area
The patented parabolic reflector generates a primary and secondary wave that spreads the shockwave over a larger surface zone.
Upon delivery, a cellular response is triggered activating the body’s natural healing process resulting in:
Increased blood supply resulting in angiogenesis –the formation of new blood vessels to increase blood flow
The proliferation of smooth muscle cells to restore tissue elasticity and support tissue remodeling and regeneration
Activation of endogenous growth factors
UroGold Works. Patient outcomes and satisfaction are outstanding. It was convenient and simple to implement into my practice. The opportunity to offer my patients a safe and effective solution that they want has been a Game Changer for my practice.
UroGold® sets a new standard in urological care by offering:
SoftWave therapy offers a superior solution for pain management with patented technology, leading to better outcomes and higher client satisfaction:
UroGold® is not just a treatment option, it’s a practice enhancement tool, providing:
SoftWave’s patented broad-focused shockwave therapy devices are FDA-cleared and effective at treating a variety of soft tissue injuries and conditions.
UroGold® harnesses patented shockwave technology for a non-invasive, drug-free approach to urological care, offering effective, researched, and convenient treatment that reaches wide and deep for superior outcomes.
SoftWave provides extensive training, operational guidelines, and clinical support to ensure the successful integration of UroGold® into your practice, enhancing both patient outcomes and clinic efficiency.
With its quick, easy-to-administer sessions that can be administered by a trained staff member, UroGold® seamlessly complements existing treatment protocols, providing a valuable addition to urological care services.
